Does TADALAFIL Cause Pulmonary hypertension? 428 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 428 reports of Pulmonary hypertension have been filed in association with TADALAFIL (Esokalli Testosterone Booster Oral Dissolving Film). This represents 1.4% of all adverse event reports for TADALAFIL.
428
Reports of Pulmonary hypertension with TADALAFIL
1.4%
of all TADALAFIL reports
121
Deaths
251
Hospitalizations
How Dangerous Is Pulmonary hypertension From TADALAFIL?
Of the 428 reports, 121 (28.3%) resulted in death, 251 (58.6%) required hospitalization, and 22 (5.1%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TADALAFIL. However, 428 reports have been filed with the FAERS database.
What Other Side Effects Does TADALAFIL Cause?
Headache (3,196)
Drug ineffective (2,943)
Dyspnoea (2,881)
Death (1,917)
Diarrhoea (1,667)
Dizziness (1,374)
Nausea (1,368)
Asthenia (1,230)
Fatigue (1,135)
Hypertension (1,044)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
RIOCIGUAT (411)
ADALIMUMAB (287)
DASATINIB (249)
Which TADALAFIL Alternatives Have Lower Pulmonary hypertension Risk?
TADALAFIL vs TAFAMIDIS
TADALAFIL vs TAFAMIDIS MEGLUMINE
TADALAFIL vs TAFASITAMAB
TADALAFIL vs TAFASITAMAB-CXIX
TADALAFIL vs TAFINLAR